Kazia Therapeutics Limited. (KZIA) Financial Statements
Kazia Therapeutics Limited. (KZIA) files with the U.S. Securities and Exchange Commission under CIK 0001075880. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- 42.00 thousand AUD
- Net Income
- -20.70 million AUD
- Total Assets
- 6.06 million AUD
- Net Cash from Operations
- -13.28 million AUD
Fiscal year ended Jun 30, 2025. Latest periodic SEC filing: Nov 7, 2025. Source: SEC filings (EDGAR XBRL). Amounts in AUD.
Open the full financial statements for KZIA in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History